Location History:
- Ranheim, NO (2000 - 2002)
- Oslo, NO (2020)
- Trondheim, NO (2004 - 2021)
- Tromso, NO (2017 - 2021)
Company Filing History:
5 out of 5 
3 out of 7 
2 out of 25 
Years Active: 2000-2021
Title: Kurt Ingar Draget: Innovator in Oral Pharmaceutical Compositions
Introduction
Kurt Ingar Draget, an esteemed inventor based in Trondheim, Norway, has made significant contributions to the field of oral pharmaceutical compositions. With a remarkable portfolio of 14 patents, Draget's innovative approaches have led to advancements that enhance the efficacy and delivery of medicinal compounds.
Latest Patents
Among his latest inventions, Draget's work on an emulsion stands out. This invention relates to an orally administrable chewable composition in unit dosage form, which features an oil-in-water emulsion where the aqueous phase is gelled. The oil phase is composed of a physiologically tolerable unsaturated fatty acid ester. Another notable patent is focused on oral pharmaceutical dispersion compositions. This invention provides an oral pharmaceutical composition, which may be in dose unit form, that comprises a lipophilic drug substance dispersed in a physiologically tolerable aqueous carrier. This carrier is preferably an aqueous gel and is characterized by its pH being strategically managed around a functional electrostatic group's pKa value, allowing for improved drug delivery options.
Career Highlights
Draget has held prominent roles in companies such as Vitux Group AS and NTNU Technology Transfer AS, where he has utilized his expertise to push the boundaries of pharmaceutical innovation. His work in these firms has allowed him to integrate academic research with practical applications, fostering a collaborative environment for further inventions in the field.
Collaborations
Throughout his career, Draget has collaborated with talented individuals such as Ingvild Johanne Haug and Catherine Taylor. These partnerships have been instrumental in developing his inventions and enhancing their viability and application in the pharmaceutical industry.
Conclusion
Kurt Ingar Draget exemplifies the spirit of innovation, contributing to the advancement of oral pharmaceutical compositions through his numerous patents and collaborations. His work not only showcases his inventive prowess but also underscores the importance of teamwork in the realm of scientific discovery. As he continues to innovate, his contributions are sure to impact the field of pharmaceuticals positively.